Treatment of central serous chorioretinopathy with topical NSAIDs
Sepehr Bahadorani,1 Kyle Maclean,1 Kendall Wannamaker,1 Edward Rickie Chu,1 Nathan Gresores,2 Jeong-Hyeon Sohn,1 Roberto Diaz-Rohena,1 Michael A Singer21Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; 2Medical Center Ophthalmology Associat...
Saved in:
Main Authors: | Bahadorani S, Maclean K, Wannamaker K, Chu ER, Gresores N, Sohn JH, Diaz-Rohena R, Singer MA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/3d09e27f5f2a41e68a9509b25d8f3f63 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
by: Mohabati D, et al.
Published: (2020) -
Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy
by: Ambiya V, et al.
Published: (2016) -
Central Serous Chorioretinopathy: Pathogenesis and Management
by: Semeraro F, et al.
Published: (2019) -
Deep Learning for Detecting Subretinal Fluid and Discerning Macular Status by Fundus Images in Central Serous Chorioretinopathy
by: Fabao Xu, et al.
Published: (2021) -
Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study
by: Doepfner JM, et al.
Published: (2018)